JPMorgan raises target for Viatris stock from USD 18.00 to USD 20.00

Published on 10/25/2026 at 14:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JPMorgan set a USD 20.00 target for Viatris stock on October 21, 2026. Pacira deal value was USD 1.65 billion, with results due November 5, 2026.

Deal and valuation context

Viatris agreed to acquire Pacira for USD 1.65 billion on October 8, 2026.
JPMorgan raised its target from USD 18.00 to USD 20.00 on October 21, 2026.
Viatris will report third-quarter 2026 results on November 5, 2026.

Bauhaus-Stil Poster mit geometrischen Formen in Rot Blau Gelb und dem Wort MEDIA — Paramount Global (US92556V1061) Bauhaus-Poster mit geometrischen Formen und Schriftzug MEDIA repräsentiert Medienbranche, Illustration mit AI erstellt.

Viatris Inc. is preparing for a higher analyst target after JPMorgan raised its price objective from USD 18.00 to USD 20.00 on October 21, 2026, according to MarketScreener. The note kept a Neutral rating.

Pacira adds a strategic test

The latest corporate catalyst is Viatris' agreement to acquire Pacira BioSciences for USD 36.50 per share in cash, valuing the transaction at USD 1.65 billion. The deal was announced on October 8, 2026, and is expected to close by the end of 2026, subject to customary conditions, according to Viatris.

What does the target signal?

JPMorgan's move places the new USD 20.00 target above the USD 18.00 Nasdaq closing price cited for October 23, 2026. The difference is USD 2.00, while the same market reference showed a 52-week range of USD 9.92 to USD 18.75 and a market capitalization of USD 20.7 billion.

The next reporting date

Viatris is scheduled to report third-quarter 2026 financial results on November 5, 2026. The company said the results call will also discuss the Pacira transaction, giving investors a defined date for the next financial update.

Market context for Viatris

Viatris operates across branded, generic, complex generic and innovative medicines, with its primary listing on Nasdaq under ticker VTRS. The company had a market capitalization of USD 20.7 billion as of October 23, 2026, while its 52-week range extended from USD 9.92 to USD 18.75.

The further course of trading is shown by the continuously updated real-time quote of Viatris stock.